Patients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, ...

The National Health Mission’s plan is part of a playbook to combat obesity and curtail unhealthy eating habits.

In just a few years, weight-loss drugs like Ozempic and Wegovy have become a global sensation. They promise to do something ...

A 'Blue Bloods' Star Is Joining Donnie Wahlberg for His New Spin-Off In 1965, the government tried replacing migrant workers ...

Hairy Biker Si King has called for action following a damning report that shows not only does the North East have the highest ...

India’s growing obesity epidemic, especially among youth, poses a major public health risk. Here’s why preventive healthcare ...

Professor Amelia Lake, dietitian and public health nutritionist at Teesside University, writes about health inequalities ...

PEOPLE on weight-loss jabs start piling the flab back on just two months after they stop taking them, research shows. The ...

For decades, the public narrative around obesity has largely centered on a simple equation: eat less, move more. But a ...

GLP-1 drugs came out in 2005 as a Type 2 diabetes treatment. But in recent years their popularity for weight loss -- and the cost -- has taken off.

GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little evidence of improving cardiorespiratory fitness, researchers say.

CLEVELAND - A new study published by Cleveland Clinic researchers investigating the genetic underpinnings of weight loss response has identified a ...